Breast Neoplasms: all 12,820 studies

Page 113 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.

• Safety and Efficacy Study of HER2/Neu (E75) Vaccine in Breast CancerCompletedNCT00854789Phase 1
• The Effects of Peri-Operative Pregabalin on Post-Operative Pain Following Breast Cancer Surgery With Axillary Node Dissection: A Pilot StudyCompletedNCT00852683Phase 3
• Docetaxel With or Without a Phytochemical in Treating Patients With Breast CancerTerminatedNCT00852332Phase 2
• Adjuvant Breast Cancer Study of the Netherlands Working Party for Autotransplantation in Solid TumorsTerminatedNCT00851110Phase 2
• Gene Polymorphisms and Gene Products as Biological Markers of Aging and Correlation With Clinical Geriatric Assessment, Tolerance of Chemotherapy and Outcome in Elderly Breast Cancer PatientsCompletedNCT00849758
• Gene Therapy in Treating Women With Metastatic Breast CancerCompletedNCT00849459Phase 1
• A Study to Examine the Effects of Esomeprazole on the Pharmacokinetics of Orally Administered Lapatinib in Subjects With Metastatic ErbB2 Positive Breast CancerCompletedNCT00849329Phase 1
• ATAC - Arimidex, Tamoxifen Alone or in CombinationCompletedNCT00849030Phase 3
• A Study of Circulating Endothelial Cell as Marker for Avastin (Bevacizumab) in Combination With Docetaxel Plus Xeloda (Capecitabine) as First Line Treatment for Patients With Locally Recurrent and Metastatic Breast CancerTerminatedNCT00845910Phase 2
• Efficacy Study of Single Agent Trastuzumab or Lapatinib to Treat HER2-Overexpressing Breast CancerStatus unknownNCT00842998Phase 2
• Safety and Efficacy Study of HER2/Neu (E75) Vaccine in Node-Positive Breast Cancer PatientsCompletedNCT00841399Phase 1
• Total Xenoestrogen Body Burden in Relation to Mammographic Density, a Marker of Breast Cancer RliskCompletedNCT00839696
• Breast Cancers: Risk Factors Among Mexican Women in Mexico, Mexican-American and African-American Women in the U.S.CompletedNCT00837499
• A Study of Pregnancy and Pregnancy Outcomes in Women With Breast Cancer Treated With Trastuzumab, Pertuzumab in Combination With Trastuzumab, or Ado-Trastuzumab EmtansineCompletedNCT00833963
• Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064)CompletedNCT00831545Phase 2
• The Clinical and Economic Impact of Pharmacogenomic Testing for Tamoxifen Metabolism in Postmenopausal Women Receiving Tamoxifen for Prevention of Recurrent Breast CancerCompletedNCT00830973
• Multimedia Educational Program for Patients With Early-Stage Prostate Cancer or Breast CancerCompletedNCT00830635Not applicable
• Study of Neoadjuvant Chemotherapy of Breast CancerStatus unknownNCT00830544Phase 2
• Acupuncture for Aromatase Inhibitor Induced Joint PainCompletedNCT00826397Not applicable
• Phase 1/2 Study of ThermoDox With Approved Hyperthermia in Treatment of Breast Cancer Recurrence at the Chest WallCompletedNCT00826085Phase 1/2
• Topical Cyclosporine vs. Placebo for Epiphora Associated With DocetaxelWithdrawnNCT00824811Phase 2
• Data Collection Study of Raw Thermal Images for the Purpose of Developing a Device for Early Detection of Breast CancerCompletedNCT00821613
• Post-treatment Care of Breast Cancer SurvivorsCompletedNCT00821288Not applicable
• A Study to Examine the Effects of Low and High-fat Meals on Orally Administered Lapatinib in Metastatic ErbB2 Positive Breast Cancer PatientsCompletedNCT00821054Phase 1
• Study of Lapatinib in Breast Cancer Patients With HER-2 Non-amplified Primary Tumors and HER-2 Positive or EGFR Positive Circulating Tumor CellsTerminatedNCT00820924Phase 2
• Neoadjuvant Chemotherapy in Locally Advanced Breast CancerStatus unknownNCT00820690
• Efficacy and Tolerance Study of Bevacizumab in Her2- Inflammatory Breast Cancer PatientsCompletedNCT00820547Phase 2
• Radiation Therapy in Treating Women Who Have Undergone Breast Conservation Surgery and Systemic Therapy for Early Breast CancerStatus unknownNCT00818051Phase 3
• Efficacy and Safety of IPI-504 With Trastuzumab Pretreated, Locally Advanced or Metastatic HER2 Positive Breast CancerTerminatedNCT00817362Phase 2
• Liposuction for Arm Lymphedema Following Breast Cancer SurgeryCompletedNCT00816985Not applicable
• PET/CT Guided Fulvestrant Therapy for Patients With Recurrent or Metastatic Breast CancerTerminatedNCT00816582Not applicable
• A Clinical Study to Evaluate Somo•v and Digital Mammography Together as a Breast Cancer Screening Method, Compared to Digital Mammography Alone, in Women With Dense Breasts.CompletedNCT00816530
• Study of Statin as Neo-Adjuvant Therapy in Postmenopausal Breast CancerCompletedNCT00816244Phase 2
• CYP2D6 Genotyping by AmpliChipTM CYP450 for Tamoxifen-Treated Breast Cancer PatientsStatus unknownNCT00815555
• Radiation Therapy in Women With Low Risk Early-Stage Breast Cancer Who Have Undergone Breast Conservation SurgeryStatus unknownNCT00814567Not applicable
• ATAC - Endometrial Sub-ProtocolCompletedNCT00814125Phase 3
• Coagulation Parameters in Postmenopausal Breast Cancer Patients Under Adjuvant Hormonal TherapyCompletedNCT00814034
• A Phase 2 Study of Standard Chemotherapy Plus BSI-201 (a PARP Inhibitor) in the Neoadjuvant Treatment of Triple Negative Breast CancerCompletedNCT00813956Phase 2
• Nipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast DiseaseTerminatedNCT00813878
• Effects of Physical Activity and Dietary Change in Minority Breast Cancer SurvivorsCompletedNCT00811824Phase 2
• Trial to Evaluate the Therapeutic Benefit of Fulvestrant in Combination With ZACTIMA in Postmenopausal Women With Bone Predominant, Hormone Receptor Positive Metastatic Breast CancerCompletedNCT00811369Phase 2
• Adjuvant Post-Tamoxifen Exemestane TrialTerminatedNCT00810706Phase 3
• Arimidex Bone Mass Index and Oral BisphosphonatesCompletedNCT00809484
• Prevention of Breast Cancer: As Simple as hCG-A Randomized Clinical Trial in High Risk WomenStatus unknownNCT00808522Phase 3
• Chemotherapy Monitoring With Breast Computed Tomography (CT)CompletedNCT00808041
• Phase II Study of Simvastatin in Primary Breast Cancer; Test of Its Potential Selectivity on Basal Subtype Breast CancerStatus unknownNCT00807950Phase 2
• Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast CancerCompletedNCT00807859Phase 1
• Mammaglobin-A DNA Vaccine for Metastatic Breast CancerCompletedNCT00807781Phase 1
• Early Detection and Prediction of Chemotherapy Induced Cardiac Toxicity in Breast Cancer PatientsCompletedNCT00806507
• Clinical Trial of Postmastectomy Radiotherapy in Breast Cancer With One to Three Positive NodesTerminatedNCT00805597Phase 3
• Clinical Trial of the Combination of Intravenous Alvespimycin (KOS-1022), Trastuzumab With or Without Paclitaxel in Patients With Advanced Solid Tumor Malignancies or Her2 Positive Metastatic Breast Cancer Who Have Previously Failed Trastuzumab TherapyCompletedNCT00803556Phase 1
• Pilot Study to Validate Metallic Markers for Image Guided Radiation Therapy for Breast Cancer TxCompletedNCT00802932
• 3-Dimensional Conformal Radiation Therapy or Internal Radiation Therapy After Breast-Conserving Surgery in Treating Women With Stage I or Stage II Breast CancerTerminatedNCT00802711Not applicable
• Pre-operative Magnetic Resonance Imaging (MRI) in Young Breast Cancer PatientsStatus unknownNCT00801476Not applicable
• Cyclophosphamide and Docetaxel or Doxorubicin in Treating Women With Newly Diagnosed Breast Cancer That Can Be Removed by SurgeryStatus unknownNCT00801411Phase 2
• Panther: A Study Comparing Biweekly and Tailored EC-T Versus Three Weekly FEC-T in Breast Cancer PatientsActive, not recruitingNCT00798070Phase 3
• Monitoring of Breast Tissue Change Due to Hormone Replacement Therapy in Post-menopausal Women Using OBSCompletedNCT00797199
• Taxol Epirubicin Cyclophosphamide Herceptin Neoadjuvant (TECHNO)CompletedNCT00795899Phase 2
• Chemotherapeutic Agents in Brain/BreastCompletedNCT00795678
• Flaxseed in Preventing Breast Cancer in Premenopausal Women at Risk of Developing Breast CancerTerminatedNCT00794989Not applicable
• A Phase Ⅲ Randomized Clinical Trial of Postmastectomy Hypofractionation Radiotherapy in High-risk Breast CancerCompletedNCT00793962Phase 3
• Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Docetaxel (AC-Doc) Versus Dose-Dense Doxorubicin and Docetaxel (ADoc) in Breast CancerCompletedNCT00793377Phase 3
• Trial of Ixabepilone in Patients With HER-2 Negative Metastatic Breast Cancer (HIT)TerminatedNCT00790894Phase 2
• Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer AgentsCompletedNCT00790816Phase 1
• A Trial l of Panobinostat Given in Combination With Trastuzumab and Paclitaxel in Adult Female Patients With HER2 Positive Metastatic Breast CancerCompletedNCT00788931Phase 1
• A Prospective Study to Evaluate FDG-PET, Breast MRI, and Breast Ultrasonography in Monitoring Tumour Responses in Patients With Locally Advanced Breast Cancer (LABC) Undergoing Neoadjuvant ChemotherapyCompletedNCT00788489
• Combination Study of BMS-754807 and Herceptin® in Patients With Advanced or Metastatic Her-2-positive Breast CancerCompletedNCT00788333Phase 1/2
• Research Of Quality Of Life And Safety Outcomes Of Postmenopausal Breast Cancer Patients Switching From Tamoxifen Therapy To Aromatase Inhibitor TherapyCompletedNCT00784888
• ATAC - Pharmacokinetics (PK) Sub-ProtocolCompletedNCT00784862Phase 3
• Effects of Rapid Genetic Counseling and Testing in Newly Diagnosed Breast Cancer PatientsCompletedNCT00783822Not applicable
• TOBI to Monitor Response to Neoadjuvant Therapy in Breast CancerCompletedNCT00783757Not applicable
• Clinical Trial of Intravenous Alvespimycin in Patients With Her2 Positive Breast CancerTerminatedNCT00780000Phase 2
• A Study to Evaluate Safety and Efficacy of Caelyx in Combination With Cyclophosphamide in the Treatment of Metastatic Breast Cancer (P02948)CompletedNCT00779129Phase 2
• Preoperative Chemotherapy in Triple Negative Invasive Breast Cancer That Can be Removed by Surgery.Status unknownNCT00777673Phase 2
• Lynne Cohen Consortium Project: Multi-Center Database/RegistryCompletedNCT00776958
• Tailored Neoadjuvant Chemotherapy for Stage II/III Breast Cancer With Tumor Size More Than 2 cmCompletedNCT00776724Phase 3
• Use of Molecular Breast Imaging (MBI) to Detect Additional Disease in Women With Breast Cancer Who Are About to go to SurgeryCompletedNCT00776308
• Study of AVE1642 (IGF-1R/CD221) in Combination With Fulvestrant (Faslodex®) in Postmenopausal Patients With Advanced Hormono-dependent Breast CancerTerminatedNCT00774878Phase 2
• Weight Reduction Intervention for Breast Cancer SurvivorsCompletedNCT00774371Not applicable
• PRIMADOS Study:A Study of Avastin (Bevacizumab) Plus Docetaxel for First Line Treatment of Patients With Metastatic Breast CancerWithdrawnNCT00774241Phase 4
• A Study of Bevacizumab (Avastin) in Combination With Neoadjuvant Treatment Regimens in Participants With Primary Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast CancerCompletedNCT00773695Phase 2
• Male Breast Cancer Summa Health System/Akron City Hospital Experience 1995-2007CompletedNCT00773669
• Clinical Trial of the Combination of Trastuzumab (Herceptin) and Tanespimycin in Patients With Solid Tumors and Her2 Positive Metastatic Breast Cancer That Have Previously Failed HerceptinCompletedNCT00773344Phase 1/2
• Study of the Effect of Glutamine Supplementation on Chemotherapy Induced Toxicities in Breast Cancer PatientsCompletedNCT00772824Phase 4
• G-CSF in Preventing Neutropenia in Women Receiving Chemotherapy for Breast CancerCompletedNCT00771433Phase 2
• A Study to Determine the Value of 18F-FAZA PET Imaging in Patients With Breast CancerTerminatedNCT00771381Phase 2
• Phase II Study of AS1402 Combined With Letrozole to Treat Breast CancerTerminatedNCT00770354Phase 2
• Internet Use Among Women With Recurrent Metastatic Breast CancerCompletedNCT00770055Not applicable
• Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone MetastasesWithdrawnNCT00769990Phase 1/2
• The Impact of Lymphedema on Breast Cancer SurvivorsCompletedNCT00769821
• Docetaxel, Carboplatin, and Trastuzumab and/or Lapatinib in Treating Women With Stage I, Stage II, or Stage III Breast Cancer That Can Be Removed by SurgeryCompletedNCT00769470Phase 2
• The Performance of Patient Support Program in Early Stage Breast CancerCompletedNCT00769080
• Trastuzumab in a Neo-adjuvant Regimen for HER2+ Breast Cancer - the TRAIN StudyCompletedNCT00768859Phase 2
• An Open Label Non-Interventional Evaluation of the Effect of Adjuvant Hormonal Treatment of Postmenopausal Women Wih Early Breast Cancer With Aromatase Inhibitors on Bone Mineral Density and Bone Fracture Rate in Daily PracticeCompletedNCT00767585
• Studying Urine and Blood Samples in Women With Newly Diagnosed Breast CancerCompletedNCT00766454
• Phase IB/II Trial Combining Vinorelbine With Sorafenib as First-Line Treatment in Patients With Metastatic Breast CancerStatus unknownNCT00764972Phase 1/2
• Study of Artesunate in Metastatic Breast CancerCompletedNCT00764036Phase 1
• Efficacy of Tomosynthesis in the BIRADS 3 PopulationCompletedNCT00763100
• Anastrozole and LetrozoleCompletedNCT00762294
• Comparison of Zometa Retention and Effect in Multiple Myeloma and Breast CancerCompletedNCT00760370Phase 2

← Breast Neoplasms overview